Back to results

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients (frontMIND)

Primary Purpose

Diffuse Large B-cell Lymphoma

Status

Active

Phase

Phase 3

Locations

International

Study Type

Interventional

Intervention

Tafasitamab

Lenalidomide

Rituximab

Cyclophosphamide

Doxorubicin

Vincristine

Prednisone

Tafasitamab placebo

Lenalidomide placebo

About this trial

This is an interventional treatment trial for Diffuse Large B-cell Lymphoma focused on measuring DLBCL, CD19, monoclonal antibody, tafasitamab, lenalidomide, R-CHOP, Diffuse Large B-cell Lymphoma

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Major Inclusion Criteria:

Previously untreated patients with local biopsy-proven, CD20-positive DLBCL, including one of the following diagnoses by 2016 World Health Organization (WHO) classification of lymphoid neoplasms are eligible:
1. DLBCL, NOS including GCB type, ABC type
2. T-cell rich large BCL
3. Epstein-Barr virus-positive DLBCL, NOS
4. Anaplastic lymphoma kinase (ALK)-positive large BCL
5. Human herpes virus-8 (HHV8)-positive DLBCL, NOS
6. High-grade BCL with MYC and B-cell lymphoma 2 (BCL2) and/or B-cell lymphoma 6 (BCL6) rearrangements (double-hit or triple-hit lymphoma). Please note: Patients must be appropriate candidates for R-CHOP. If an investigator deems a patient with a known double- or triple-hit lymphoma (HGBL) should be treated more aggressively (e.g. dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab [DA-EPOCH-R] or cyclophosphamide, vincristine, doxorubicin and dexamethasone (CVAD) followed by methotrexate and cytarabine [Hyper CVAD]), this patient would not be considered eligible for this study
7. DLBCL coexistent with either follicular lymphoma (FL) of any grade, gastric MALT lymphoma or non-gastric MALT lymphoma
8. FL grade 3b
Availability of archival or freshly collected tumor tissue sent for retrospective central pathology review
IPI status of 3 to 5 (for patients > 60 years of age) or aaIPI 2 to 3 (for patients ≤ 60 years of age)
Diagnosis to treatment interval, defined as the time between the date of DLBCL diagnosis (date of the first biopsy specimen containing lymphoma according to the local pathology report) and the start of treatment (C1D1) ≤ 28 days
ECOG performance status of 0, 1, or 2
Left ventricular ejection fraction equal to or greater than lower limit of institutional normal range, assessed by local echocardiography or cardiac multi-gated acquisition (MUGA) scan
Adequate hematologic function
Female participants: Agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods and refrain from breast feeding and donating eggs; agreement to ongoing pregnancy testing during the course of the study, and after study therapy has ended
Male participants: agreement to remain abstinent (refrain from heterosexual intercourse) or use a condom and agreement to refrain from donating sperm

Major Exclusion Criteria:

Any other histological type of lymphoma according to WHO 2016 classification of lymphoid neoplasms, e.g., primary mediastinal (thymic) large B-cell lymphoma, Burkitt's lymphoma, BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma); primary effusion lymphoma; primary cutaneous DLBCL, leg type; primary DLBCL of the CNS; DLBCL arising from CLL or indolent lymphoma
History of prior non-hematologic malignancy except for the following:
1. Malignancy treated with curative intent and with no evidence of active disease present for more than 2 years before screening
2. Adequately treated lentigo maligna melanoma without current evidence of disease or adequately controlled non-melanomatous skin cancer
3. Adequately treated carcinoma in situ without current evidence of disease
Any systemic anti-lymphoma and/or investigational therapy prior to the start of C1D1, except for permitted pre-phase treatment
Contraindication to any of the individual components of R-CHOP, including prior receipt of anthracyclines
Known CNS lymphoma involvement
Known active systemic bacterial, viral, fungal, or other infection at screening, including patients with suspected active or latent tuberculosis (as confirmed by a positive interferon-gamma release assay)
History or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that in the investigator's opinion would preclude participation in the study or compromise the patient's ability to give informed consent

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Tafasitamab plus lenalidomide in addition to R-CHOP

Tafasitamab placebo plus lenalidomide placebo in addition to R-CHOP

Arm Description

Patients will receive tafasitamab plus lenalidomide in addition to R-CHOP for six 21-day cycles: Tafasitamab dose: 12 mg/kg body weight. Each 21-day cycle (cycles 1-6) will comprise of a tafasitamab IV infusion on Day 1, Day 8 and Day 15. Lenalidomide dose: 25 mg as a starting dose per os (orally) once per day on Days 1-10 of each 21-day cycle R-CHOP dose: Rituximab (or locally approved biosimilar) 375 mg/m2, IV Day 1 of every 21-day cycle; Cyclophosphamide 750 mg/m2, IV Day 1 of 21-day cycle; Doxorubicin 50 mg/m2, IV Day 1 of 21-day cycle; Vincristine 1.4 mg/m2 (max 2 mg) IV Day 1 of 21-day cycle; Prednisone/prednisolone 100 mg/day, per os, Day 1-5 of every 21-day cycle

Patients will receive tafasitamab placebo plus lenalidomide placebo in addition to R-CHOP for six 21-day cycles: Tafasitamab placebo: 0.9% saline solution Days 1, 8 and 15 of each 21-day cycle Lenalidomide placebo: Days 1-10 of each 21-day cycle R-CHOP dose: Rituximab (or locally approved biosimilar) 375 mg/m2, IV Day 1 of every 21-day cycle; Cyclophosphamide 750 mg/m2, IV Day 1 of 21-day cycle; Doxorubicin 50 mg/m2, IV Day 1 of 21-day cycle; Vincristine 1.4 mg/m2 (max 2 mg) IV Day 1 of 21-day cycle; Prednisone/prednisolone 100 mg/day, per os, Day 1-5 of every 21-day cycle

Outcomes

Primary Outcome Measures

PFS-INV

Progression-Free Survival as assessed by the investigator using the Lugano Response Criteria for Malignant Lymphoma

Secondary Outcome Measures

EFS-INV

Event-Free Survival as assessed by the investigator using the Lugano Response Criteria for Malignant Lymphoma

Overall Survival

Metabolic PET-negative CR-rate at EOT by BIRC

Metabolic PET-negative CR rate defined as the proportion of patients who achieved metabolic PET-negative CR as per Lugano 2014 criteria based on PET/CTs performed at the end of the treatment by BIRC

Metabolic PET-negative CR-rate at EOT by INV

Metabolic PET-negative CR rate defined as the proportion of patients who achieved metabolic PET-negative CR as per Lugano 2014 criteria based on PET/CTs performed at the end of the treatment by the investigator

ORR as per INV at EOT

Overall response rate defined as the proportion of patients with CR or PR as per Lugano 2014 criteria based on assessment at the end of the treatment by the INV

Time to next anti-lymphoma treatment (TTNT)

TTNT is defined as the time from randomization date to start of next anti-lymphoma therapy (for any reason including disease progression, treatment toxicity, and patient preference) or death due to any cause, whatever comes first.

Duration of Complete Response (CR) as assessed by the investigator

Duration of CR is defined as the time from the date of the first occurrence of a documented CR, to the date of progression, relapse, or death from any cause, whichever is earlier for the subgroup of patients with a Best Overall Response (BOR) of CR.

EFS at 3 years

Event-Free Survival as assessed by the investigator

PFS at 3 years

Progression-Free Survival as assessed by the investigator

OS at 3 years

Overall Survival

Full Information

NCT ID

NCT04824092

First Posted

March 22, 2021

Last Updated

April 4, 2023

Sponsor

MorphoSys AG

1. Study Identification

Unique Protocol Identification Number

NCT04824092

Brief Title

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Acronym

frontMIND

Official Title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreated, High-intermediate and High-risk Patients With Newly-diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Study Type

Interventional

2. Study Status

Record Verification Date

April 2023

Overall Recruitment Status

Active, not recruiting

Study Start Date

May 11, 2021 (Actual)

Primary Completion Date

June 2025 (Anticipated)

Study Completion Date

May 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

MorphoSys AG

4. Oversight

Studies a U.S. FDA-regulated Drug Product

Yes

Studies a U.S. FDA-regulated Device Product

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

This is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial designed to compare the efficacy and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed DLBCL

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Diffuse Large B-cell Lymphoma

Keywords

DLBCL, CD19, monoclonal antibody, tafasitamab, lenalidomide, R-CHOP, Diffuse Large B-cell Lymphoma

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 3

Interventional Study Model

Parallel Assignment

Masking

ParticipantCare ProviderInvestigatorOutcomes Assessor

Allocation

Randomized

Enrollment

899 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Tafasitamab plus lenalidomide in addition to R-CHOP

Arm Type

Experimental

Arm Description

Arm Title

Tafasitamab placebo plus lenalidomide placebo in addition to R-CHOP

Arm Type

Placebo Comparator

Arm Description

Intervention Type

Drug

Intervention Name(s)

Tafasitamab

Other Intervention Name(s)

Monjuvi

Intervention Description

Tafasitamab IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Lenalidomide

Intervention Description

Lenalidomide PO will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Rituximab

Intervention Description

Rituximab IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Cyclophosphamide

Intervention Description

Cyclophosphamide IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Doxorubicin

Intervention Description

Doxorubicin IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Vincristine

Intervention Description

Vincristine IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Prednisone

Intervention Description

Prednisone PO will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Tafasitamab placebo

Intervention Description

0.9% saline solution IV infusion will be administered as per the schedule specified in the respective arm.

Intervention Type

Drug

Intervention Name(s)

Lenalidomide placebo

Intervention Description

Placebo matching to lenalidomide PO will be administered as per the schedule specified in the respective arm.

Primary Outcome Measure Information:

Title

PFS-INV

Description

Progression-Free Survival as assessed by the investigator using the Lugano Response Criteria for Malignant Lymphoma

Time Frame

Time from date of randomization until Progressive Disease or death from any cause. In this trial, the primary endpoint is PFS as assessed by the investigator (up to 43 months)

Secondary Outcome Measure Information:

Title

EFS-INV

Description

Event-Free Survival as assessed by the investigator using the Lugano Response Criteria for Malignant Lymphoma

Time Frame

From randomization until the first occurrence of disease progression or relapse as assessed by the INV using, start of new anti-lymphoma treatment or death from any cause, whichever occurs first (up to 43 months)

Title

Description

Overall Survival

Time Frame

From randomization until the date of death from any cause (up to 62 months)

Title

Metabolic PET-negative CR-rate at EOT by BIRC

Description

Metabolic PET-negative CR rate defined as the proportion of patients who achieved metabolic PET-negative CR as per Lugano 2014 criteria based on PET/CTs performed at the end of the treatment by BIRC

Time Frame

End of treatment, 4-8 weeks after last dose

Title

Metabolic PET-negative CR-rate at EOT by INV

Description

Time Frame

End of treatment, 4-8 weeks after last dose

Title

ORR as per INV at EOT

Description

Overall response rate defined as the proportion of patients with CR or PR as per Lugano 2014 criteria based on assessment at the end of the treatment by the INV

Time Frame

6 ± 2 weeks after End of Treatment

Title

Time to next anti-lymphoma treatment (TTNT)

Description

Time Frame

From randomization date to start of next anti-lymphoma therapy (for any reason including disease progression, treatment toxicity, and patient preference) or death due to any cause, whatever comes first (up to 43 months)

Title

Duration of Complete Response (CR) as assessed by the investigator

Description

Time Frame

From the date of the first occurrence of a documented CR, to the date of progression, relapse, or death from any cause, whichever is earlier (up to 43 months)

Title

EFS at 3 years

Description

Event-Free Survival as assessed by the investigator

Time Frame

36 months after randomization

Title

PFS at 3 years

Description

Progression-Free Survival as assessed by the investigator

Time Frame

36 months after randomization

Title

OS at 3 years

Description

Overall Survival

Time Frame

36 months after randomization

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Maximum Age & Unit of Time

80 Years

Accepts Healthy Volunteers

Eligibility Criteria

Major Inclusion Criteria: Previously untreated patients with local biopsy-proven, CD20-positive DLBCL, including one of the following diagnoses by 2016 World Health Organization (WHO) classification of lymphoid neoplasms are eligible: DLBCL, NOS including GCB type, ABC type T-cell rich large BCL Epstein-Barr virus-positive DLBCL, NOS Anaplastic lymphoma kinase (ALK)-positive large BCL Human herpes virus-8 (HHV8)-positive DLBCL, NOS High-grade BCL with MYC and B-cell lymphoma 2 (BCL2) and/or B-cell lymphoma 6 (BCL6) rearrangements (double-hit or triple-hit lymphoma). Please note: Patients must be appropriate candidates for R-CHOP. If an investigator deems a patient with a known double- or triple-hit lymphoma (HGBL) should be treated more aggressively (e.g. dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab [DA-EPOCH-R] or cyclophosphamide, vincristine, doxorubicin and dexamethasone (CVAD) followed by methotrexate and cytarabine [Hyper CVAD]), this patient would not be considered eligible for this study HGBL-NOS DLBCL coexistent with either follicular lymphoma (FL) of any grade, gastric MALT lymphoma or non-gastric MALT lymphoma FL grade 3b Availability of archival or freshly collected tumor tissue sent for retrospective central pathology review IPI status of 3 to 5 (for patients > 60 years of age) or aaIPI 2 to 3 (for patients ≤ 60 years of age) Diagnosis to treatment interval, defined as the time between the date of DLBCL diagnosis (date of the first biopsy specimen containing B Cell lymphoma according to the local pathology report) and the start of treatment (C1D1) ≤ 28 days ECOG performance status of 0, 1, or 2 Left ventricular ejection fraction equal to or greater 50% as assessed by local echocardiography or cardiac multi-gated acquisition (MUGA) scan Adequate hematologic function Female participants: Agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods and refrain from breast feeding and donating eggs; agreement to ongoing pregnancy testing during the course of the study, and after study therapy has ended Male participants: agreement to remain abstinent (refrain from heterosexual intercourse) or use a condom and agreement to refrain from donating sperm Major Exclusion Criteria: Any other histological type of lymphoma according to WHO 2016 classification of lymphoid neoplasms, e.g., primary mediastinal (thymic) large B-cell lymphoma, Burkitt's lymphoma, BCL, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma (grey-zone lymphoma); primary effusion lymphoma; primary cutaneous DLBCL, leg type; primary DLBCL of the CNS; DLBCL arising from CLL or indolent lymphoma History of prior non-hematologic malignancy except for the following: Malignancy treated with curative intent and with no evidence of active disease present for more than 2 years before screening Adequately treated lentigo maligna melanoma without current evidence of disease or adequately controlled non-melanomatous skin cancer Adequately treated carcinoma in situ without current evidence of disease Any systemic anti-lymphoma and/or investigational therapy prior to the start of C1D1, except for permitted pre-phase treatment Contraindication to any of the individual components of R-CHOP, including prior receipt of anthracyclines Known CNS lymphoma involvement Known active systemic bacterial, viral, fungal, or other infection at screening, including patients with suspected active or latent tuberculosis (as confirmed by a positive interferon-gamma release assay) History or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that in the investigator's opinion would preclude participation in the study or compromise the patient's ability to give informed consent

Facility Information:

Facility Name

MorphoSys Research Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35209

Country

United States

Facility Name

MorphoSys Research Site

City

Daphne

State/Province

Alabama

ZIP/Postal Code

36526

Country

United States

Facility Name

MorphoSys Research Site

City

Anchorage

State/Province

Alaska

ZIP/Postal Code

99508

Country

United States

Facility Name

MorphoSys Research Site

City

Chandler

State/Province

Arizona

ZIP/Postal Code

85224

Country

United States

Facility Name

MorphoSys Research Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85711

Country

United States

Facility Name

MorphoSys Research Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85719

Country

United States

Facility Name

Morphosys Research Site

City

Jonesboro

State/Province

Arkansas

ZIP/Postal Code

72401

Country

United States

Facility Name

MorphoSys Research Site

City

Anaheim

State/Province

California

ZIP/Postal Code

92801

Country

United States

Facility Name

MorphoSys Research Site

City

Bakersfield

State/Province

California

ZIP/Postal Code

92123

Country

United States

Facility Name

MorphoSys Research Site

City

Berkeley

State/Province

California

ZIP/Postal Code

94704

Country

United States

Facility Name

MorphoSys Research Site

City

Clovis

State/Province

California

ZIP/Postal Code

93611

Country

United States

Facility Name

MorphoSys Research Site

City

Fullerton

State/Province

California

ZIP/Postal Code

92834-4138

Country

United States

Facility Name

MorphoSys Research Site

City

Harbor City

State/Province

California

ZIP/Postal Code

90710

Country

United States

Facility Name

MorphoSys Research Site

City

Los Alamitos

State/Province

California

ZIP/Postal Code

90720

Country

United States

Facility Name

MorphoSys Research Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90017

Country

United States

Facility Name

MorphoSys Research Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90033

Country

United States

Facility Name

MorphoSys Research Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90048

Country

United States

Facility Name

MorphoSys Research Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90404

Country

United States

Facility Name

MorphoSys Research Site

City

San Diego

State/Province

California

ZIP/Postal Code

92123

Country

United States

Facility Name

MorphoSys Research Site

City

Santa Barbara

State/Province

California

ZIP/Postal Code

93105

Country

United States

Facility Name

MorphoSys Research Site

City

Whittier

State/Province

California

ZIP/Postal Code

90603

Country

United States

Facility Name

MorphoSys Research Site

City

Aurora

State/Province

Colorado

ZIP/Postal Code

80012

Country

United States

Facility Name

MorphoSys Research Site

City

Grand Junction

State/Province

Colorado

ZIP/Postal Code

81501

Country

United States

Facility Name

MorphoSys Research Site

City

Newark

State/Province

Delaware

ZIP/Postal Code

19713

Country

United States

Facility Name

MorphoSys Research Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32207

Country

United States

Facility Name

MorphoSys Research Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32224

Country

United States

Facility Name

MorphoSys Research Site

City

Miami Lakes

State/Province

Florida

ZIP/Postal Code

33014

Country

United States

Facility Name

MorphoSys Research Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33176

Country

United States

Facility Name

MorphoSys Research Site

City

Orange City

State/Province

Florida

ZIP/Postal Code

32763

Country

United States

Facility Name

MorphoSys Research Site

City

Atlanta

State/Province

Georgia

ZIP/Postal Code

30341

Country

United States

Facility Name

MorphoSys Research Site

City

Marietta

State/Province

Georgia

ZIP/Postal Code

30060

Country

United States

Facility Name

MorphoSys Research Site

City

Honolulu

State/Province

Hawaii

ZIP/Postal Code

96813

Country

United States

Facility Name

MorphoSys Research Site

City

Chicago

State/Province

Illinois

ZIP/Postal Code

60612

Country

United States

Facility Name

MorphoSys Research Site

City

Niles

State/Province

Illinois

ZIP/Postal Code

60714

Country

United States

Facility Name

MorphoSys Research Site

City

Park Ridge

State/Province

Illinois

ZIP/Postal Code

60068

Country

United States

Facility Name

MorphoSys Research Site

City

Skokie

State/Province

Illinois

ZIP/Postal Code

60076

Country

United States

Facility Name

MorphoSys Research Site

City

Wichita

State/Province

Kansas

ZIP/Postal Code

67214

Country

United States

Facility Name

MorphoSys Research Site

City

Lexington

State/Province

Kentucky

ZIP/Postal Code

40536-0293

Country

United States

Facility Name

MorphoSys Research Site

City

Louisville

State/Province

Kentucky

ZIP/Postal Code

40241

Country

United States

Facility Name

MorphoSys Research Site

City

New Orleans

State/Province

Louisiana

ZIP/Postal Code

70112

Country

United States

Facility Name

MorphoSys Research Site

City

Baltimore

State/Province

Maryland

ZIP/Postal Code

21237

Country

United States

Facility Name

MorphoSys Research Site

City

Bethesda

State/Province

Maryland

ZIP/Postal Code

20817-7847

Country

United States

Facility Name

MorphoSys Research Site

City

Columbia

State/Province

Maryland

ZIP/Postal Code

21044

Country

United States

Facility Name

MorphoSys Research Site

City

Detroit

State/Province

Michigan

ZIP/Postal Code

48202

Country

United States

Facility Name

MorphoSys Research Site

City

Farmington Hills

State/Province

Michigan

ZIP/Postal Code

48334

Country

United States

Facility Name

MorphoSys Research Site

City

Southfield

State/Province

Michigan

ZIP/Postal Code

48075

Country

United States

Facility Name

MorphoSys Research Site

City

Sterling Heights

State/Province

Michigan

ZIP/Postal Code

48314

Country

United States

Facility Name

MorphoSys Research Site

City

Minneapolis

State/Province

Minnesota

ZIP/Postal Code

55426

Country

United States

Facility Name

MorphoSys Research Site

City

Rochester

State/Province

Minnesota

ZIP/Postal Code

55905

Country

United States

Facility Name

MorphoSys Research Site

City

Kansas City

State/Province

Missouri

ZIP/Postal Code

64132

Country

United States

Facility Name

MorphoSys Research Site

City

Billings

State/Province

Montana

ZIP/Postal Code

59102

Country

United States

Facility Name

MorphoSys Research Site

City

Omaha

State/Province

Nebraska

ZIP/Postal Code

68130

Country

United States

Facility Name

MorphoSys Research Site

City

Las Vegas

State/Province

Nevada

ZIP/Postal Code

89148-6702

Country

United States

Facility Name

MorphoSys Research Site

City

Lebanon

State/Province

New Hampshire

ZIP/Postal Code

03755

Country

United States

Facility Name

MorphoSys Research Site

City

Florham Park

State/Province

New Jersey

ZIP/Postal Code

07932

Country

United States

Facility Name

MorphoSys Research Site

City

Morristown

State/Province

New Jersey

ZIP/Postal Code

07962

Country

United States

Facility Name

MorphoSys Research Site

City

Bronx

State/Province

New York

ZIP/Postal Code

10467

Country

United States

Facility Name

MorphoSys Research Site

City

Buffalo

State/Province

New York

ZIP/Postal Code

14263

Country

United States

Facility Name

MorphoSys Research Site

City

Oneida

State/Province

New York

ZIP/Postal Code

13421

Country

United States

Facility Name

MorphoSys Research Site

City

Rochester

State/Province

New York

ZIP/Postal Code

14642

Country

United States

Facility Name

MorphoSys Research Site

City

Asheville

State/Province

North Carolina

ZIP/Postal Code

28806

Country

United States

Facility Name

MorphoSys Research Site

City

Canton

State/Province

Ohio

ZIP/Postal Code

44718

Country

United States

Facility Name

MorphoSys Research Site

City

Cincinnati

State/Province

Ohio

ZIP/Postal Code

45219

Country

United States

Facility Name

MorphoSys Research Site

City

Cincinnati

State/Province

Ohio

ZIP/Postal Code

45242

Country

United States

Facility Name

MorphoSys Research Site

City

Oklahoma City

State/Province

Oklahoma

ZIP/Postal Code

73142

Country

United States

Facility Name

MorphoSys Research Site

City

Eugene

State/Province

Oregon

ZIP/Postal Code

97401

Country

United States

Facility Name

MorphoSys Research Site

City

Danville

State/Province

Pennsylvania

ZIP/Postal Code

17822-4910

Country

United States

Facility Name

MorphoSys Research Site

City

Pittsburgh

State/Province

Pennsylvania

ZIP/Postal Code

15224

Country

United States

Facility Name

MorphoSys Research Site

City

Charleston

State/Province

South Carolina

ZIP/Postal Code

29414

Country

United States

Facility Name

MorphoSys Research Site

City

Greenville

State/Province

South Carolina

ZIP/Postal Code

29607

Country

United States

Facility Name

MorphoSys Research Site

City

Greenville

State/Province

South Carolina

ZIP/Postal Code

29615

Country

United States

Facility Name

MorphoSys Research Site

City

Chattanooga

State/Province

Tennessee

ZIP/Postal Code

37404

Country

United States

Facility Name

MorphoSys Research Site

City

Germantown

State/Province

Tennessee

ZIP/Postal Code

38138

Country

United States

Facility Name

MorphoSys Research Site

City

Nashville

State/Province

Tennessee

ZIP/Postal Code

37203

Country

United States

Facility Name

MorphoSys Research Site

City

Austin

State/Province

Texas

ZIP/Postal Code

78745

Country

United States

Facility Name

MorphoSys Research Site

City

Bedford

State/Province

Texas

ZIP/Postal Code

76022

Country

United States

Facility Name

MorphoSys Research Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75246

Country

United States

Facility Name

MorphoSys Research Site

City

Denison

State/Province

Texas

ZIP/Postal Code

75020

Country

United States

Facility Name

MorphoSys Research Site

City

Denton

State/Province

Texas

ZIP/Postal Code

76201

Country

United States

Facility Name

MorphoSys Research Site

City

Fort Worth

State/Province

Texas

ZIP/Postal Code

76104

Country

United States

Facility Name

MorphoSys Research Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77030-1501

Country

United States

Facility Name

MorphoSys Research Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77030

Country

United States

Facility Name

MorphoSys Research Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77056

Country

United States

Facility Name

MorphoSys Research Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77090

Country

United States

Facility Name

MorphoSys Research Site

City

McAllen

State/Province

Texas

ZIP/Postal Code

78503

Country

United States

Facility Name

MorphoSys Research Site

City

Plano

State/Province

Texas

ZIP/Postal Code

75075-778

Country

United States

Facility Name

MorphoSys Research Site

City

Sugar Land

State/Province

Texas

ZIP/Postal Code

77479

Country

United States

Facility Name

MorphoSys Research Site

City

Tyler

State/Province

Texas

ZIP/Postal Code

75702

Country

United States

Facility Name

MorphoSys Research Site

City

Ogden

State/Province

Utah

ZIP/Postal Code

84405

Country

United States

Facility Name

MorphoSys Research Site

City

Salt Lake City

State/Province

Utah

ZIP/Postal Code

84112

Country

United States

Facility Name

MorphoSys Research Site

City

Gainesville

State/Province

Virginia

ZIP/Postal Code

20155

Country

United States

Facility Name

MorphoSys Research Site

City

Roanoke

State/Province

Virginia

ZIP/Postal Code

24014

Country

United States

Facility Name

MorphoSys Research Site

City

Virginia Beach

State/Province

Virginia

ZIP/Postal Code

23456

Country

United States

Facility Name

MorphoSys Research Site

City

Everett

State/Province

Washington

ZIP/Postal Code

98201

Country

United States

Facility Name

MorphoSys Research Site

City

Olympia

State/Province

Washington

ZIP/Postal Code

98502

Country

United States

Facility Name

MorphoSys Research Site

City

Seattle

State/Province

Washington

ZIP/Postal Code

98108

Country

United States

Facility Name

MorphoSys Research Site

City

Tacoma

State/Province

Washington

ZIP/Postal Code

98405

Country

United States

Facility Name

MorphoSys Research Site

City

Marshfield

State/Province

Wisconsin

ZIP/Postal Code

54449

Country

United States

Facility Name

MorphoSys Research Site

City

Buenos Aires

ZIP/Postal Code

1426

Country

Argentina

Facility Name

MorphoSys Research Site

City

Buenos Aires

ZIP/Postal Code

C1118AAT

Country

Argentina

Facility Name

MorphoSys Research Site

City

Buenos Aires

ZIP/Postal Code

C1181ACH

Country

Argentina

Facility Name

MorphoSys Research Site

City

Cipolletti

ZIP/Postal Code

8324

Country

Argentina

Facility Name

MorphoSys Research Site

City

Mendoza

ZIP/Postal Code

5500

Country

Argentina

Facility Name

MorphoSys Research Site

City

Pilar

ZIP/Postal Code

B1629AHJ

Country

Argentina

Facility Name

MorphoSys Research Site

City

Rosario

ZIP/Postal Code

2000

Country

Argentina

Facility Name

MorphoSys Research Site

City

San Miguel de Tucuman

ZIP/Postal Code

T4000IVL

Country

Argentina

Facility Name

MorphoSys Research Site

City

Adelaide

ZIP/Postal Code

5000

Country

Australia

Facility Name

MorphoSys Research Site

City

Ballarat

ZIP/Postal Code

3353

Country

Australia

Facility Name

MorphoSys Research Site

City

Birtinya

ZIP/Postal Code

4575

Country

Australia

Facility Name

MorphoSys Research Site

City

Brisbane

ZIP/Postal Code

4101

Country

Australia

Facility Name

MorphoSys Research Site

City

Canberra

ZIP/Postal Code

2605

Country

Australia

Facility Name

MorphoSys Research Site

City

Clayton

ZIP/Postal Code

3168

Country

Australia

Facility Name

MorphoSys Research Site

City

Darlinghurst

ZIP/Postal Code

2010

Country

Australia

Facility Name

MorphoSys Research Site

City

Frankston

ZIP/Postal Code

VIC 3199

Country

Australia

Facility Name

MorphoSys Research Site

City

Geelong

ZIP/Postal Code

3220

Country

Australia

Facility Name

MorphoSys Research Site

City

Gold Coast

ZIP/Postal Code

QLD 4217

Country

Australia

Facility Name

MorphoSys Research Site

City

Gosford

ZIP/Postal Code

2250

Country

Australia

Facility Name

MorphoSys Research Site

City

Greenslopes

ZIP/Postal Code

4120

Country

Australia

Facility Name

MorphoSys Research Site

City

Hobart

ZIP/Postal Code

7000

Country

Australia

Facility Name

MorphoSys Research Site

City

Kingswood

ZIP/Postal Code

2747

Country

Australia

Facility Name

MorphoSys Research Site

City

Kogarah

ZIP/Postal Code

2217

Country

Australia

Facility Name

MorphoSys Research Site

City

Launceston

ZIP/Postal Code

TAS 7250

Country

Australia

Facility Name

MorphoSys Research Site

City

Malvern

ZIP/Postal Code

3144

Country

Australia

Facility Name

MorphoSys Research Site

City

Melbourne

ZIP/Postal Code

3065

Country

Australia

Facility Name

MorphoSys Research Site

City

Melbourne

ZIP/Postal Code

3084

Country

Australia

Facility Name

MorphoSys Research Site

City

Nedlands

ZIP/Postal Code

6009

Country

Australia

Facility Name

MorphoSys Research Site

City

Perth

ZIP/Postal Code

6000

Country

Australia

Facility Name

MorphoSys Research Site

City

Perth

ZIP/Postal Code

6150

Country

Australia

Facility Name

MorphoSys Research Site

City

Richmond

ZIP/Postal Code

3121

Country

Australia

Facility Name

MorphoSys Research Site

City

St. Albans

ZIP/Postal Code

3021

Country

Australia

Facility Name

MorphoSys Research Site

City

Sydney

ZIP/Postal Code

2050

Country

Australia

Facility Name

MorphoSys Research Site

City

Sydney

ZIP/Postal Code

2145

Country

Australia

Facility Name

MorphoSys Research Site

City

Townsville

ZIP/Postal Code

4817

Country

Australia

Facility Name

MorphoSys Research Site

City

Wahroonga

ZIP/Postal Code

8833

Country

Australia

Facility Name

MorphoSys Research Site

City

Waratah

ZIP/Postal Code

2298

Country

Australia

Facility Name

MorphoSys Research Site

City

Wollongong

ZIP/Postal Code

2500

Country

Australia

Facility Name

MorphoSys Research Site

City

Graz

ZIP/Postal Code

8036

Country

Austria

Facility Name

MorphoSys Research Site

City

Innsbruck

ZIP/Postal Code

6020

Country

Austria

Facility Name

MorphoSys Research Site

City

Linz

ZIP/Postal Code

4010

Country

Austria

Facility Name

MorphoSys Research Site

City

Linz

ZIP/Postal Code

4021

Country

Austria

Facility Name

MorphoSys Research Site

City

Rankweil

ZIP/Postal Code

6830

Country

Austria

Facility Name

MorphoSys Research Site

City

St. Poelten

ZIP/Postal Code

3100

Country

Austria

Facility Name

MorphoSys Research Site

City

Vienna

ZIP/Postal Code

1090

Country

Austria

Facility Name

MorphoSys Research Site

City

Vienna

ZIP/Postal Code

1140

Country

Austria

Facility Name

MorphoSys Research Site

City

Vienna

ZIP/Postal Code

A-1020

Country

Austria

Facility Name

MorphoSys Research Site

City

Edmonton

ZIP/Postal Code

T6G 1Z2

Country

Canada

Facility Name

MorphoSys Research Site

City

Halifax

ZIP/Postal Code

B3H 2A7

Country

Canada

Facility Name

MorphoSys Research Site

City

London

ZIP/Postal Code

N6A 5W9

Country

Canada

Facility Name

MorphoSys Research Site

City

Montreal

ZIP/Postal Code

H3T 1E2

Country

Canada

Facility Name

MorphoSys Research Site

City

Saskatoon

ZIP/Postal Code

S7N 4H4

Country

Canada

Facility Name

MorphoSys Research Site

City

Sherbrooke

ZIP/Postal Code

J1G 2E8

Country

Canada

Facility Name

MorphoSys Research Site

City

Cali

ZIP/Postal Code

490042

Country

Colombia

Facility Name

MorphoSys Research Site

City

Medellin

ZIP/Postal Code

050034

Country

Colombia

Facility Name

MorphoSys Research Site

City

Sabaneta

ZIP/Postal Code

055450

Country

Colombia

Facility Name

MorphoSys Research Site

City

Valledupar

ZIP/Postal Code

20001

Country

Colombia

Facility Name

MorphoSys Research Site

City

Brno

ZIP/Postal Code

625 00

Country

Czechia

Facility Name

MorphoSys Research Site

City

Hradec Králové

ZIP/Postal Code

500 05

Country

Czechia

Facility Name

MorphoSys Research Site

City

Olomouc

ZIP/Postal Code

775 20

Country

Czechia

Facility Name

MorphoSys Research Site

City

Ostrava

ZIP/Postal Code

708 52

Country

Czechia

Facility Name

MorphoSys Research Site

City

Prague

ZIP/Postal Code

100 34

Country

Czechia

Facility Name

MorphoSys Research Site

City

Prague

ZIP/Postal Code

110 00

Country

Czechia

Facility Name

MorphoSys Research Site

City

Prague

ZIP/Postal Code

150 06

Country

Czechia

Facility Name

Morphosys Research Site

City

Caen

State/Province

Cedex 9

Country

France

Facility Name

Morphosys Research Site

City

Bordeau

State/Province

Pessac Cedax

Country

France

Facility Name

MorphoSys Research Site

City

Amiens

ZIP/Postal Code

14033

Country

France

Facility Name

MorphoSys Research Site

City

Bordeaux

ZIP/Postal Code

33074

Country

France

Facility Name

MorphoSys Research Site

City

Bordeaux

ZIP/Postal Code

33076

Country

France

Facility Name

MorphoSys Research Site

City

La Tronche

ZIP/Postal Code

38700

Country

France

Facility Name

Morphosys Research Site

City

Le Chesnay

Country

France

Facility Name

MorphoSys Research Site

City

Le Mans

ZIP/Postal Code

72037

Country

France

Facility Name

MorphoSys Research Site

City

Lille

ZIP/Postal Code

59020

Country

France

Facility Name

MorphoSys Research Site

City

Limoges

ZIP/Postal Code

87042

Country

France

Facility Name

MorphoSys Research Site

City

Marseille

ZIP/Postal Code

13385

Country

France

Facility Name

MorphoSys Research Site

City

Montpellier

ZIP/Postal Code

34295

Country

France

Facility Name

MorphoSys Research Site

City

Nantes

ZIP/Postal Code

44093

Country

France

Facility Name

MorphoSys Research Site

City

Poitiers

ZIP/Postal Code

86021

Country

France

Facility Name

MorphoSys Research Site

City

Quimper

ZIP/Postal Code

29107

Country

France

Facility Name

MorphoSys Research Site

City

Saint-Priest-en-Jarez

ZIP/Postal Code

42270

Country

France

Facility Name

MorphoSys Research Site

City

Vandoeuvre-lès-Nancy

Country

France

Facility Name

MorphoSys Research Site

City

Vannes

ZIP/Postal Code

56017

Country

France

Facility Name

MorphoSys Research Site

City

Aachen

ZIP/Postal Code

52074

Country

Germany

Facility Name

MorphoSys Research Site

City

Augsburg

ZIP/Postal Code

86156

Country

Germany

Facility Name

MorphoSys Research Site

City

Bad Berka

ZIP/Postal Code

99437

Country

Germany

Facility Name

MorphoSys Research Site

City

Berlin

ZIP/Postal Code

10967

Country

Germany

Facility Name

MorphoSys Research Site

City

Berlin

ZIP/Postal Code

12203

Country

Germany

Facility Name

MorphoSys Research Site

City

Berlin

ZIP/Postal Code

13353

Country

Germany

Facility Name

Morphosys Research Site

City

Berlin

Country

Germany

Facility Name

MorphoSys Research Site

City

Bochum

ZIP/Postal Code

44791

Country

Germany

Facility Name

MorphoSys Research Site

City

Bonn

ZIP/Postal Code

53127

Country

Germany

Facility Name

MorphoSys Research Site

City

Chemnitz

ZIP/Postal Code

09116

Country

Germany

Facility Name

MorphoSys Research Site

City

Cologne

ZIP/Postal Code

50937

Country

Germany

Facility Name

MorphoSys Research Site

City

Cottbus

ZIP/Postal Code

03048

Country

Germany

Facility Name

MorphoSys Research Site

City

Duesseldorf

ZIP/Postal Code

40479

Country

Germany

Facility Name

MorphoSys Research Site

City

Essen

ZIP/Postal Code

45147

Country

Germany

Facility Name

MorphoSys Research Site

City

Göttingen

ZIP/Postal Code

37075

Country

Germany

Facility Name

MorphoSys Research Site

City

Halle

ZIP/Postal Code

06120

Country

Germany

Facility Name

MorphoSys Research Site

City

Hamburg

ZIP/Postal Code

20099

Country

Germany

Facility Name

MorphoSys Research Site

City

Heilbronn

ZIP/Postal Code

D-74078

Country

Germany

Facility Name

MorphoSys Research Site

City

Jena

ZIP/Postal Code

07747

Country

Germany

Facility Name

MorphoSys Research Site

City

Kassel

ZIP/Postal Code

34125

Country

Germany

Facility Name

MorphoSys Research Site

City

Kiel

ZIP/Postal Code

24105

Country

Germany

Facility Name

MorphoSys Research Site

City

Luebeck

ZIP/Postal Code

23538

Country

Germany

Facility Name

MorphoSys Research Site

City

Magdeburg

ZIP/Postal Code

39120

Country

Germany

Facility Name

MorphoSys Research Site

City

Mainz

ZIP/Postal Code

55131

Country

Germany

Facility Name

MorphoSys Research Site

City

Mannheim

ZIP/Postal Code

68167

Country

Germany

Facility Name

MorphoSys Research Site

City

Marburg

ZIP/Postal Code

35043

Country

Germany

Facility Name

MorphoSys Research Site

City

Muenster

ZIP/Postal Code

48149

Country

Germany

Facility Name

MorphoSys Research Site

City

Munich

ZIP/Postal Code

81675

Country

Germany

Facility Name

MorphoSys Research Site

City

Munich

ZIP/Postal Code

81737

Country

Germany

Facility Name

MorphoSys Research Site

City

Mutlangen

ZIP/Postal Code

73557

Country

Germany

Facility Name

MorphoSys Research Site

City

Nuernberg

ZIP/Postal Code

90419

Country

Germany

Facility Name

MorphoSys Research Site

City

Paderborn

ZIP/Postal Code

33098

Country

Germany

Facility Name

MorphoSys Research Site

City

Rostock

ZIP/Postal Code

18057

Country

Germany

Facility Name

MorphoSys Research Site

City

Tuebingen

ZIP/Postal Code

65199

Country

Germany

Facility Name

MorphoSys Research Site

City

Wiesbaden

ZIP/Postal Code

65191

Country

Germany

Facility Name

MorphoSys Research Site

City

Wuerzburg

ZIP/Postal Code

97080

Country

Germany

Facility Name

MorphoSys Research Site

City

Wuppertal

ZIP/Postal Code

42283

Country

Germany

Facility Name

MorphoSys Research Site

City

Kowloon

Country

Hong Kong

Facility Name

MorphoSys Research Site

City

Lai Chi Kok

Country

Hong Kong

Facility Name

MorphoSys Research Site

City

Sha Tin

Country

Hong Kong

Facility Name

MorphoSys Research Site

City

Budapest

ZIP/Postal Code

1085

Country

Hungary

Facility Name

MorphoSys Research Site

City

Budapest

ZIP/Postal Code

H-1122

Country

Hungary

Facility Name

MorphoSys Research Site

City

Debrecen

ZIP/Postal Code

4032

Country

Hungary

Facility Name

MorphoSys Research Site

City

Gyor

ZIP/Postal Code

9024

Country

Hungary

Facility Name

MorphoSys Research Site

City

Kecskemet

ZIP/Postal Code

H-6000

Country

Hungary

Facility Name

Morphosys Research Site

City

Nyíregyháza

Country

Hungary

Facility Name

MorphoSys Research Site

City

Pécs

ZIP/Postal Code

H-7624

Country

Hungary

Facility Name

MorphoSys Research Site

City

Szeged

ZIP/Postal Code

H-6725

Country

Hungary

Facility Name

MorphoSys Research Site

City

Dublin

Country

Ireland

Facility Name

MorphoSys Research Site

City

Galway City

Country

Ireland

Facility Name

MorphoSys Research Site

City

Limerick

Country

Ireland

Facility Name

MorphoSys Research Site

City

Be'er Sheva

ZIP/Postal Code

8410101

Country

Israel

Facility Name

MorphoSys Research Site

City

Haifa

ZIP/Postal Code

31096

Country

Israel

Facility Name

MorphoSys Research Site

City

Jerusalem

ZIP/Postal Code

9112001

Country

Israel

Facility Name

MorphoSys Research Site

City

Petah-Tikva

ZIP/Postal Code

49100

Country

Israel

Facility Name

Morphosys Research Site

City

Ramat Gan

Country

Israel

Facility Name

MorphoSys Research Site

City

Tel-Aviv

ZIP/Postal Code

6423906

Country

Israel

Facility Name

MorphoSys Research Site

City

Bari

ZIP/Postal Code

70124

Country

Italy

Facility Name

MorphoSys Research Site

City

Bergamo

ZIP/Postal Code

24127

Country

Italy

Facility Name

MorphoSys Research Site

City

Bologna

ZIP/Postal Code

40138

Country

Italy

Facility Name

MorphoSys Research Site

City

Brescia

ZIP/Postal Code

25123

Country

Italy

Facility Name

MorphoSys Research Site

City

Candiolo

ZIP/Postal Code

10060

Country

Italy

Facility Name

MorphoSys Research Site

City

Catania

ZIP/Postal Code

95123

Country

Italy

Facility Name

MorphoSys Research Site

City

Forli

ZIP/Postal Code

47014

Country

Italy

Facility Name

MorphoSys Research Site

City

Genoa

ZIP/Postal Code

16132

Country

Italy

Facility Name

MorphoSys Research Site

City

Lecce

ZIP/Postal Code

73100

Country

Italy

Facility Name

MorphoSys Research Site

City

Milan

ZIP/Postal Code

20141

Country

Italy

Facility Name

MorphoSys Research Site

City

Novara

ZIP/Postal Code

28100

Country

Italy

Facility Name

MorphoSys Research Site

City

Orbassano

ZIP/Postal Code

10043

Country

Italy

Facility Name

MorphoSys Research Site

City

Padova

ZIP/Postal Code

35128

Country

Italy

Facility Name

MorphoSys Research Site

City

Palermo

ZIP/Postal Code

90146

Country

Italy

Facility Name

MorphoSys Research Site

City

Pavia

ZIP/Postal Code

27100

Country

Italy

Facility Name

MorphoSys Research Site

City

Ravenna

ZIP/Postal Code

48121

Country

Italy

Facility Name

MorphoSys Research Site

City

Rimini

ZIP/Postal Code

47923

Country

Italy

Facility Name

MorphoSys Research Site

City

Rome

ZIP/Postal Code

00189

Country

Italy

Facility Name

MorphoSys Research Site

City

Rozzano

ZIP/Postal Code

20089

Country

Italy

Facility Name

MorphoSys Research Site

City

Siena

ZIP/Postal Code

15121

Country

Italy

Facility Name

MorphoSys Research Site

City

Siena

ZIP/Postal Code

53100

Country

Italy

Facility Name

MorphoSys Research Site

City

Terni

ZIP/Postal Code

05100

Country

Italy

Facility Name

MorphoSys Research Site

City

Tricase

ZIP/Postal Code

73039

Country

Italy

Facility Name

MorphoSys Research Site

City

Trieste

ZIP/Postal Code

34129

Country

Italy

Facility Name

MorphoSys Research Site

City

Turin

ZIP/Postal Code

10126

Country

Italy

Facility Name

MorphoSys Research Site

City

Chiba

ZIP/Postal Code

260-8717

Country

Japan

Facility Name

MorphoSys Research Site

City

Fukuoka

ZIP/Postal Code

810-8563

Country

Japan

Facility Name

MorphoSys Research Site

City

Gifu

ZIP/Postal Code

500-8513

Country

Japan

Facility Name

MorphoSys Research Site

City

Ibaraki

ZIP/Postal Code

311-3193

Country

Japan

Facility Name

MorphoSys Research Site

City

Isehara

ZIP/Postal Code

259-1193

Country

Japan

Facility Name

MorphoSys Research Site

City

Kagoshima

ZIP/Postal Code

890-8520

Country

Japan

Facility Name

MorphoSys Research Site

City

Kanazawa

ZIP/Postal Code

920-8641

Country

Japan

Facility Name

MorphoSys Research Site

City

Kashiwa-shi

ZIP/Postal Code

227-8577

Country

Japan

Facility Name

MorphoSys Research Site

City

Kobe

ZIP/Postal Code

650-0047

Country

Japan

Facility Name

MorphoSys Research Site

City

Matsuyama

ZIP/Postal Code

791-0280

Country

Japan

Facility Name

MorphoSys Research Site

City

Nagoya

ZIP/Postal Code

466-8650

Country

Japan

Facility Name

MorphoSys Research Site

City

Narita-shi

ZIP/Postal Code

286-8520

Country

Japan

Facility Name

MorphoSys Research Site

City

Okayama

ZIP/Postal Code

701-1192

Country

Japan

Facility Name

MorphoSys Research Site

City

Osakasayama-shi

ZIP/Postal Code

589-8511

Country

Japan

Facility Name

MorphoSys Research Site

City

Osaka

ZIP/Postal Code

565-0871

Country

Japan

Facility Name

MorphoSys Research Site

City

Saitama

ZIP/Postal Code

350-0495

Country

Japan

Facility Name

MorphoSys Research Site

City

Sapporo

ZIP/Postal Code

003-0804

Country

Japan

Facility Name

MorphoSys Research Site

City

Sendai

ZIP/Postal Code

980-8574

Country

Japan

Facility Name

MorphoSys Research Site

City

Tachikawa

ZIP/Postal Code

190-0014

Country

Japan

Facility Name

MorphoSys Research Site

City

Tokyo

ZIP/Postal Code

113-8603

Country

Japan

Facility Name

MorphoSys Research Site

City

Tokyo

ZIP/Postal Code

142-8666

Country

Japan

Facility Name

MorphoSys Research Site

City

Tokyo

ZIP/Postal Code

162-8666

Country

Japan

Facility Name

MorphoSys Research Site

City

Tsu-shi

ZIP/Postal Code

514-8507

Country

Japan

Facility Name

MorphoSys Research Site

City

Yamagata

ZIP/Postal Code

990-9585

Country

Japan

Facility Name

MorphoSys Research Site

City

Yokohama

ZIP/Postal Code

241-8515

Country

Japan

Facility Name

MorphoSys Research Site

City

Busan

ZIP/Postal Code

47392

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Busan

ZIP/Postal Code

49201

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Busan

ZIP/Postal Code

4924

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Busan

ZIP/Postal Code

49267

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Daegu

ZIP/Postal Code

42415

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Daegu

ZIP/Postal Code

42472

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Daegu

ZIP/Postal Code

42601

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Daejeon

ZIP/Postal Code

35015

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Goyang-si

ZIP/Postal Code

10408

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Incheon

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Jeonju

ZIP/Postal Code

561-712

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Jinju-si

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seongnam-si

ZIP/Postal Code

13620

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

02841

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

03080

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

03181

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

037222

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

04763

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

05505

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

06351

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

06591

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

07345

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Seoul

ZIP/Postal Code

07985

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Yangsan

ZIP/Postal Code

50612

Country

Korea, Republic of

Facility Name

MorphoSys Research Site

City

Alor Setar

ZIP/Postal Code

05460

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Ampang

ZIP/Postal Code

68000

Country

Malaysia

Facility Name

MorphoSys Research Site

City

George Town

ZIP/Postal Code

10990

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Ipoh

ZIP/Postal Code

30450

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Johor Bahru

ZIP/Postal Code

80100

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Kota Bharu

ZIP/Postal Code

16150

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Kuala Lumpur

ZIP/Postal Code

59100

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Kuantan

ZIP/Postal Code

25100

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Kuching

ZIP/Postal Code

93586

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Petaling Jaya

ZIP/Postal Code

47500

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Subang Jaya

ZIP/Postal Code

47500

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Taiping

ZIP/Postal Code

34000

Country

Malaysia

Facility Name

MorphoSys Research Site

City

Auckland

ZIP/Postal Code

1023

Country

New Zealand

Facility Name

MorphoSys Research Site

City

Bacolod City

ZIP/Postal Code

6100

Country

Philippines

Facility Name

MorphoSys Research Site

City

Cebu City

ZIP/Postal Code

6000

Country

Philippines

Facility Name

MorphoSys Research Site

City

Davao City

ZIP/Postal Code

8000

Country

Philippines

Facility Name

MorphoSys Research Site

City

Manila

ZIP/Postal Code

1000

Country

Philippines

Facility Name

MorphoSys Research Site

City

Pasig City

ZIP/Postal Code

1605

Country

Philippines

Facility Name

MorphoSys Research Site

City

Quezon City

ZIP/Postal Code

1112

Country

Philippines

Facility Name

Morphosys Research Site

City

Piła

Country

Poland

Facility Name

MorphoSys Research Site

City

Torun

ZIP/Postal Code

87-100

Country

Poland

Facility Name

MorphoSys Research Site

City

Warsaw

ZIP/Postal Code

02-781

Country

Poland

Facility Name

Morphosys Research Site

City

Łódź

Country

Poland

Facility Name

MorphoSys Research Site

City

Brasov

ZIP/Postal Code

500366

Country

Romania

Facility Name

MorphoSys Research Site

City

Bucharest

ZIP/Postal Code

010825

Country

Romania

Facility Name

MorphoSys Research Site

City

Bucharest

ZIP/Postal Code

050098

Country

Romania

Facility Name

Morphosys Research Site

City

Bucharest

Country

Romania

Facility Name

Morphosys Research Site

City

Cluj-Napoca

Country

Romania

Facility Name

Morphosys Research Site

City

Craiova

Country

Romania

Facility Name

MorphoSys Research Site

City

Iasi

ZIP/Postal Code

700483

Country

Romania

Facility Name

MorphoSys Research Site

City

Kazan

ZIP/Postal Code

420029

Country

Russian Federation

Facility Name

Morphosys Research Site

City

Moscow

Country

Russian Federation

Facility Name

MorphoSys Research Site

City

Novosibirsk

ZIP/Postal Code

630087

Country

Russian Federation

Facility Name

Morphosys Research Site

City

Petrozavodsk

Country

Russian Federation

Facility Name

MorphoSys Research Site

City

Saint Petersburg

ZIP/Postal Code

197341

Country

Russian Federation

Facility Name

MorphoSys Research Site

City

Saint Petersburg

ZIP/Postal Code

197758

Country

Russian Federation

Facility Name

Morphosys Research Site

City

Saint Petersburg

Country

Russian Federation

Facility Name

Morphosys research site

City

UFA

Country

Russian Federation

Facility Name

MorphoSys Research Site

City

Belgrade

ZIP/Postal Code

11 000

Country

Serbia

Facility Name

MorphoSys Research Site

City

Belgrade

ZIP/Postal Code

11 080

Country

Serbia

Facility Name

MorphoSys Research Site

City

Nis

ZIP/Postal Code

18 000

Country

Serbia

Facility Name

Morphosys Research Site

City

Novi Sad

Country

Serbia

Facility Name

MorphoSys Research Site

City

Sremska Kamenica

ZIP/Postal Code

21204

Country

Serbia

Facility Name

MorphoSys Research Site

City

Bratislava

ZIP/Postal Code

83310

Country

Slovakia

Facility Name

MorphoSys Research Site

City

Kosice

ZIP/Postal Code

041 90

Country

Slovakia

Facility Name

MorphoSys Research Site

City

Košice

ZIP/Postal Code

04166

Country

Slovakia

Facility Name

MorphoSys Research Site

City

Badalona

ZIP/Postal Code

08916

Country

Spain

Facility Name

MorphoSys Research Site

City

Barcelona

ZIP/Postal Code

08035

Country

Spain

Facility Name

MorphoSys Research Site

City

Barcelona

ZIP/Postal Code

08908

Country

Spain

Facility Name

MorphoSys Research Site

City

Burgos

ZIP/Postal Code

09006

Country

Spain

Facility Name

MorphoSys Research Site

City

Girona

ZIP/Postal Code

17007

Country

Spain

Facility Name

MorphoSys Research Site

City

Jerez de la Frontera

ZIP/Postal Code

11407

Country

Spain

Facility Name

MorphoSys Research Site

City

Lugo

ZIP/Postal Code

27003

Country

Spain

Facility Name

MorphoSys Research Site

City

Madrid

ZIP/Postal Code

28034

Country

Spain

Facility Name

MorphoSys Research Site

City

Madrid

ZIP/Postal Code

28040

Country

Spain

Facility Name

MorphoSys Research Site

City

Madrid

ZIP/Postal Code

28041

Country

Spain

Facility Name

MorphoSys Research Site

City

Madrid

ZIP/Postal Code

28050

Country

Spain

Facility Name

MorphoSys Research Site

City

Madrid

ZIP/Postal Code

28223

Country

Spain

Facility Name

MorphoSys Research Site

City

Majadahonda

ZIP/Postal Code

28222

Country

Spain

Facility Name

MorphoSys Research Site

City

Palma de Mallorca

ZIP/Postal Code

07198

Country

Spain

Facility Name

MorphoSys Research Site

City

Pamplona

ZIP/Postal Code

31008

Country

Spain

Facility Name

MorphoSys Research Site

City

Sabadell

ZIP/Postal Code

08208

Country

Spain

Facility Name

MorphoSys Research Site

City

Salamanca

ZIP/Postal Code

37007

Country

Spain

Facility Name

MorphoSys Research Site

City

Seville

ZIP/Postal Code

41009

Country

Spain

Facility Name

MorphoSys Research Site

City

Seville

ZIP/Postal Code

41013

Country

Spain

Facility Name

MorphoSys Research Site

City

Seville

ZIP/Postal Code

41014

Country

Spain

Facility Name

MorphoSys Research Site

City

Valencia

ZIP/Postal Code

46017

Country

Spain

Facility Name

MorphoSys Research Site

City

Vitoria-Gasteiz

ZIP/Postal Code

01009

Country

Spain

Facility Name

Morphosys Research Site

City

Chang Hua

Country

Taiwan

Facility Name

Morphosys Research Site

City

Chiayi City

ZIP/Postal Code

613

Country

Taiwan

Facility Name

Morphosys Research Site

City

Hualien City

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Kaohsiung

ZIP/Postal Code

833401

Country

Taiwan

Facility Name

Morphosys Research Site

City

Kaohsiung

Country

Taiwan

Facility Name

Morphosys Research Site

City

New Taipei City

Country

Taiwan

Facility Name

Morphosys Research Site

City

Taichung

ZIP/Postal Code

40447

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Taichung

ZIP/Postal Code

40705

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Tainan

ZIP/Postal Code

71004

Country

Taiwan

Facility Name

Morphosys Research Site

City

Tainan

ZIP/Postal Code

736

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Tainan

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Taipei

ZIP/Postal Code

100226

Country

Taiwan

Facility Name

Morphosys Research Site

City

Taipei

ZIP/Postal Code

11217

Country

Taiwan

Facility Name

Morphosys Research Site

City

Taipei

ZIP/Postal Code

112

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Taipei

ZIP/Postal Code

114490

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Taipei

Country

Taiwan

Facility Name

Morphsys Research Site

City

Taoyuan

Country

Taiwan

Facility Name

MorphoSys Research Site

City

Bangkok

ZIP/Postal Code

10400

Country

Thailand

Facility Name

Morphosys Research Site

City

Bangkok

ZIP/Postal Code

10500

Country

Thailand

Facility Name

Morphosys Research Site

City

Chiang Mai

ZIP/Postal Code

50200

Country

Thailand

Facility Name

Morphosys Research Site

City

Khon Kaen

ZIP/Postal Code

40000

Country

Thailand

Facility Name

MorphoSys Research Site

City

Pathum Thani

ZIP/Postal Code

12120

Country

Thailand

Facility Name

MorphoSys Research Site

City

Ankara

ZIP/Postal Code

06590

Country

Turkey

Facility Name

MorphoSys Research Site

City

Ankara

Country

Turkey

Facility Name

MorphoSys Research Site

City

Istanbul

ZIP/Postal Code

34390

Country

Turkey

Facility Name

MorphoSys Research Site

City

Istanbul

ZIP/Postal Code

34890

Country

Turkey

Facility Name

MorphoSys Research Site

City

Izmir

ZIP/Postal Code

35100

Country

Turkey

Facility Name

MorphoSys Research Site

City

İzmit

ZIP/Postal Code

41380

Country

Turkey

Facility Name

MorphoSys Research Site

City

Malatya

ZIP/Postal Code

44280

Country

Turkey

Facility Name

MorphoSys Research Site

City

Mersin

ZIP/Postal Code

33343

Country

Turkey

Facility Name

MorphoSys Research Site

City

Samsun

ZIP/Postal Code

55139

Country

Turkey

Facility Name

MorphoSys Research Site

City

Trabzon

ZIP/Postal Code

61080

Country

Turkey

Facility Name

Morphosys Research Site

City

Cherkasy

ZIP/Postal Code

18009

Country

Ukraine

Facility Name

Morphosys Research Site

City

Chernihiv

ZIP/Postal Code

14029

Country

Ukraine

Facility Name

Morphosys Research Site

City

Kharkiv

ZIP/Postal Code

61000

Country

Ukraine

Facility Name

Morphosys Research Site

City

Kharkiv

ZIP/Postal Code

61070

Country

Ukraine

Facility Name

MorphoSys Research Site

City

Kryvyi Rih

ZIP/Postal Code

50048

Country

Ukraine

Facility Name

Morphosys Research Site

City

Kyiv

ZIP/Postal Code

03022

Country

Ukraine

Facility Name

MorphoSys Research Site

City

Kyiv

ZIP/Postal Code

03115

Country

Ukraine

Facility Name

Morphosys Research Site

City

Kyiv

ZIP/Postal Code

03680

Country

Ukraine

Facility Name

MorphoSys Research Site

City

Kyiv

ZIP/Postal Code

04107

Country

Ukraine

Facility Name

Morphosys Research Site

City

Kyiv

ZIP/Postal Code

04112

Country

Ukraine

Facility Name

Morphosys Research Site

City

Lviv

ZIP/Postal Code

79044

Country

Ukraine

Facility Name

Morphosys Research Site

City

Poltava

ZIP/Postal Code

36011

Country

Ukraine

Facility Name

MorphoSys Research Site

City

Zhytomyr

ZIP/Postal Code

10002

Country

Ukraine

Facility Name

MorphoSys Research Site

City

Aberdeen

ZIP/Postal Code

AB25 2ZN

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Bath

ZIP/Postal Code

BA1 3NG

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Belfast

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Birmingham

ZIP/Postal Code

B15 2TH

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Bristol

ZIP/Postal Code

BS2 8ED

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

London

ZIP/Postal Code

EC1M 6BQ

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

London

ZIP/Postal Code

SM2 5PT

Country

United Kingdom

Facility Name

Morphosys Research Site

City

London

ZIP/Postal Code

SW3 6JJ

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Manchester

ZIP/Postal Code

M20 4BX

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Nottingham

ZIP/Postal Code

NG5 1PB

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Sutton

ZIP/Postal Code

SW17 0QT

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Westcliff-on-Sea

ZIP/Postal Code

SS0 0RY

Country

United Kingdom

Facility Name

MorphoSys Research Site

City

Wolverhampton

ZIP/Postal Code

WV10 0QP

Country

United Kingdom

12. IPD Sharing Statement

Plan to Share IPD

Learn more about this trial

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

We'll reach out to this number within 24 hrs

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients (frontMIND)

Diffuse Large B-cell Lymphoma

About this trial

Eligibility Criteria

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial